UTI treatment and management cost billions of health care dollars annually in both the ambulatory and the inpatient setting. An estimated 60 of women will experience at least one UTI in their lifetime. Bacteria that are prone to multiple drug resistance can lead to complications in diagnosis and treatment that contribute to increasing treatment costs and poor patient outcomes. Quidel Molecular Programs extend the continuum of diagnostic choices from rapid immunoassays to confirmatory nucleic acid testing. Urinary tract infection (UTI) is one of the most common types of bacterial infections in adults. Currently, the gold standard for UTI diagnosis is to use laboratory culture. They are a result of bacteria that can go to any part of your urinary system including your kidneys, bladder, ureters, and urethra. Although, bacteria cause 85% of UTIs, some viruses, fungi, and parasites can also infect the urinary tract. There are no highly accurate diagnostic tools available for point-of-care testing. UTI’s are also known as urinary tract infections. A urinary tract infection can affect different parts of the urinary system including the kidneys, ureters, bladder, or urethra. CoreBioLabs is a CAP accredited and CLIA certified high-complexity molecular lab. Panels Include Urine Panel, Oral Fluid Panel, and, Psych. UTIs are among the most prevalent community and hospital acquired infections, affecting almost 50% of the population at least once in their lifetime. Diagnostics for UTI, RPP, Gastrointestinal, Womens Health, Wound Care and Nail Pathology. With same day reporting, our test can allow physicians to select the most precise antibiotic for each patient to allow for better treatment and antibiotic stewardship. The PCR-Dx Molecular UTI Panel provides detailed and personalized treatment information from the start. Our molecular testing by Real-Time PCR allows for rapid pathogen identification with extreme specificity and accuracy over conventional cultures and detects antibiotic resistant genes. With the Unyvero A50 Solution, Curetis has developed a molecular diagnostics system for reliable and extremely rapid diagnosis of severe infectious diseases. Patients Choice Laboratories offers industry leading UTI molecular diagnostics with same day results.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |